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Abstract 
The messenger molecule nitric oxide (NO) is involved in blood flow regulation, cytotoxicity, and neural signalling, processes 
that are important in the physiology and pathophysiology of the mammalian cochlea. However, neither the presence of NO nor 
its synthetic enzyme, NO synthase, has been established in the peripheral auditory system. NO synthase activity, measured as the 
enzymatic conversion of radioactive arginine to citrulline, was predominantly soluble in the auditory nerve, lateral wall, vestibule 
and cochlear neuroepithelium. N-methyl-L-arginine and trifluoperazine inhibited NO synthase activity in the lateral wall and 
auditory nerve. Histochemical staining by NADPH-diaphorase localized NOS activity to the lateral wall and the neuronal 
elements of the organ of Corti. Based on these results, the predominant NO synthase isoform in the cochlea is the neuronal 
type-I isoform. 
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1. Introduct ion 
The chemical messenger nitric oxide (NO) has been 
implicated in a wide variety of biological phenomena 
including neurotransmission, cytotoxicity, and blood 
flow regulation. NO is a gas and thus can cross mem- 
branes readily and affect neighboring cells. It exerts 
many of its effects by activating the soluble isoform of 
guanylate cyclase [5], an enzyme which converts GTP 
to cGMP. The cGMP, in turn, affects cellular physiol- 
ogy through the activation of cGMP-dependent  protein 
kinases [27]. Proteins whose activities are modulated by 
this kinase include a plasma-membrane Ca2÷-ATPase 
and a N a + / C a  2÷ exchanger [14,33]. NO also affects 
cellular physiology independent of the cGMP system. 
NO stimulates the ADP-ribosylation of enzymes such 
as glyeeraldehyde-3-phosphate dehydrogenase [21], thus 
resulting in a modulation of activity. In addition, NO 
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can directly inhibit enzymes involved in the mitochon- 
drial electron transport chain [15]. Finally, as a free 
radical, NO participates in radical-mediated cell death 
by reacting with superoxide to produce the highly cyto- 
toxic compound, peroxynitrite [2]. 
NO is synthesized by the enzyme nitric oxide syn- 
thase (NOS) which catalyzes the oxidation of the termi- 
nal guanidinium nitrogen in the amino acid L-arginine 
to form NO and L-citrulline [20]. Three  distinct iso- 
forms o f  this enzyme have been characterized which 
vary in CaZ+/calmodulin dependency, subcellular lo- 
calization, mode of induction, and tissue expression. 
Type-I NOS activity is Ca2+/calmodulin-dependent,  
cytosolic and constitutively expressed [7]. First local- 
ized in brain, this isozyme has since been found in 
many locations including the pancreas [28], corpus cav- 
ernosum [8], and neurons innervating the gastrointesti- 
nal lining of the gut [34]. In these tissues, NO partici- 
pates in insulin secretion, penile erection, and peristal- 
sis, respectively. In the brain, NO synthesized by this 
isozyme may act as a neuromodulator  in glutamate 
neurotransmission [5]. Moreover, a role for NO in 
long-term potentiation has been proposed [23]. In con- 
trast to the neuronal type-I NOS, type-II NOS is not 
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constitutively expressed but can be induced in many 
tissues such as smooth muscle, macrophages, glia, and 
liver [22]. In macrophages, type-II NOS is induced in 
response to a bacterial infection, and the NO produced 
can kill the invading cells. However, the function of 
type-II NOS in other cell types is unknown. Type-Ill 
NOS is distinctly localized to the endothelial lining of 
blood vessels where NO acts as a vasodilator [24] via 
relaxation of the smooth muscle surrounding the ves- 
sel. Similar to type-I NOS, this isozyme is constitutively 
expressed and Ca2+/calmodulin dependent [18,25]. 
However, type-Ill NOS is unique among the three 
isoforms in that it is localized to the plasma membrane 
due to posttranslational N-myristoylation [29]. The va- 
sodilatory action of several hormones including 
bradykinin and acetylcholine is thought to be mediated 
by type-Ill NOS in the endothelium [16]. 
The three best studied effects of NO, modulation of 
neurotransmission, regulation of blood flow, and in- 
duction of cytotoxicity are all involved in the physiology 
or pathophysiology of the mammalian cochlea. In fact, 
several key components of the NO/cGMP signal trans- 
duction pathway have already been demonstrated in 
the sensory tissues of the inner ear. Calmodulin [30], 
cGMP [32], and a potential cGMP-dependent protein 
kinase substrate [9] are present in the neuroepithelium. 
Although NOS localization has been attempted in cen- 
tral auditory structures [12] little information concern- 
ing the presence or distribution of NOS in the cochlea 
is known. We assessed the biochemical activity of NOS 
in the lateral wall, auditory nerve, cochlear neuroep- 
ithelium, and vestibule. Using a combination of histo- 
chemical and enzymatic methods, we characterized 
NOS in these tissues and determined the location and 
nature of the NOS isoforms present in the peripheral 
auditory system. 
2. Materials and Methods 
Except where noted, all chemicals were purchased from Sigma 
chemical company (St. Louis, MO). 
NOS was localized in cochlear tissues using NADPH-diaphorase 
histochemistry. Adult pigmented guinea pigs (Murphy Laboratories, 
Plainfield, IN) were decapitated and the builae removed, opened, 
and placed in 1% paraformaidehyde in phosphate buffered saline 
(PBS). PBS consisted of 80 mM Na2HPO4, 100 mM NaC! with the 
pH adjusted to 7.5 using HCI. The cochleae were perfused with 1% 
paraformaldehyde/PBS through the round window and maintained 
in this solution for 3 h at 40C. They were then rinsed 3 times in PBS, 
and the lateral wall was removed and stained as described below. 
The modiolus containing the sensory epithelium was then removed 
from the temporal bone and placed in NADPH-diaphorase staining 
solution consisting of 0.2% Triton X-100, 1 mM nitro blue tetra- 
zolium (NBT), 1 mM NADP, 15 mM malic acid, 1 mM MnCI 2 
(Mallinckrodt, St. Louis, MO), 50 mM Tris base with the pH ad- 
justed to 8.0 using HCI. After 1 h, the reaction was stopped by 
placing the modiolus in 10 mi of PBS and dissecting the neuroepithe- 
lium. The dissected tissue was mounted onto slides using 50% 
glycerol (Merck, Rahway, N J). The tissue was visualized under 
brightfield microscopy. 
The NADPH-diaphorase reaction was also performed on cells 
isolated from neut'oepithelium. The sensory epithelium was dissected 
from freshly isolated cochleae in Hanks' Balanced Salt Solution 
(Gibco-BRL, Gaithersburg, MD) consisting of 137 mM NaCI, 5.4 
mM KCI, 1.25 mM CaCI2, 0.5 mM MgCI 2, 0.4 mM MgSO4, 0.33 mM 
Na2HPO4, 0.44 mM KH2PO4, 5.5 mM D-glucose, 5 mM N-[2-hy- 
droxyethyl]piperazine-N'-[2-ethanesulfonic acid] (HEPES) buffered 
to pH 7.4 with NaOH and adjusted to 300+2 mOsM using 4 M 
NaCI. Tissue sections containing Hensen's cells, outer hair cells and 
Deiters' cells were obtained by microdissection and incubated for 15 
min in type IV collagenase diluted to 0.5 mg/ml in Hanks' medium. 
Cells were then dispersed into a fresh droplet of Hanks' medium. 
The dissociated cells were maintained in 1% paraformaldehyde/PBS 
for 2 h at 4°C. The cells were pelleted at 1000 × g for 10 rain and 
placed onto coverslips coated with 0.1% polyethylenimine. They 
were washed several times with Hanks' medium and then incubated 
with the NADPH-diaphorase staining solution for 1 h at 37°C. 
Tissue was prepared for NOS enzymatic assays using the follow- 
ing procedure. Pigmented guinea pigs were decapitated and the 
bullae quickly removed and placed in Hanks' medium. The auditory 
nerve, neuroepithelium, lateral wall, and vestibular tissues were 
dissected and homogenized in buffer containing 50 mM HEPES, 3 
mM ethylenediaminctetraacetic acid (EDTA), 3 mM ethylene glycol- 
bis(fl-aminoethyl ether) N,N,N',N'-tetraacetic acid (EGTA) and the 
pH adjusted to 7.4. The neuroepithelium was homogenized in 25 p.l 
of this buffer whereas the other tissues were homogenized in 50/~1. 
The tissues were homogenized twice on ice using 200 /~1 glass 
microhomogenizers (Kontes Life Sciences, Vineland, NJ) and then 
centrifuged at 10,000x g for 15 rain to pellet cell membranes. In 
some experiments, the pelleted fraction was resnspended in an equal 
volume of homogenization buffer and also used for NOS activity 
determinations. The supernatant fraction was removed and cen- 
trifuged at 100,000X g for 1 h. The 100,000X g supernatant was 
used for the NOS assays. 
NOS activity in inner ear tissues was assessed using a modified 
procedure of published methods [19]. L-[2,3-3Hlarginine from New 
England Nuclear (36.1 Ci/mmol) was purified before each experi- 
ment by anion exchange chromatography. Dowex-1 resin (Cl- form) 
was added to warm ( ~ 7(PC) 1 M NaOH and allowed to settle. A 0.5 
ml column was poured and washed with H20 ( ~ 700C) until the pH 
was neutral. [3H]arginine was added to the column and the first peak 
of radioactivity was collected. This peak contained the purified 
[3H]arginine. Assays were conducted in a 30/zl volume in 16 mM 
HEPES, 3 #M calmodulin, 3 mM CaCl 2, 1 mM EDTA, 1 mM 
EGTA and 100/~M NADPH, pH 7.4. The initial [3H]arginine level 
was 250,000 dpm in all experiments except in the experiments shown 
in Fig. 3 where 400,000 dpm were added. Assays were run at room 
temperature for 15 rain except in the experiments shown in Fig. 3 
where the reaction time was extended to 60 rain. Reactions were 
terminated by the addition of 0.5 ml of buffer containing 50 mM 
HEPES, 2 mM EDTA with the pH adjusted to 5.5 using HCI. The 
entire reaction mix was loaded onto a 1 ml AG50WX-8 column (Na + 
form, BioRad, Richmond, CA) and the column was washed with 0.5 
ml of the buffer used to terminate the reaction. The column retained 
[3H]arginine and excluded 13Hkitrulline as confirmed by thin layer 
chromatographic analysis (see below). 
Enzyme activities were determined by subtracting the dpm in the 
citrulline fraction of a control reaction (-NADPH) from the experi- 
mental value. NOS specific activity was expressed as dpm of 
[3H]citrulline formed min -I  mg protein -1. Protein concentrations 
were determined using the BioRad protein assay kit (BioRad, Rich- 
mond, CA) and bovine serum albumin as standard. 
Arginine to citrulline conversion was also determined using thin 
layer chromatography (TLC). Auditory nerve tissue from 6 cochleae 
was homogenized as described above and the 10,000× g supernatant 
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was used. The reaction volume was increased to 100/zl. At 10 min 
intervals, 10 /zl aliquots of the reaction mix were spotted onto a 
20× 20 cm silica gel G TLC plate (Uniplate cat# 80013, Newark, 
DE). Unlabeled L-arginine and L-citrulline (26 and 18 ~g respec- 
tively) were added as carriers. The spots were dried and the plate 
was developed in 5:30:2:5 n-butanol:acetone:diethylamine:water. The 
plates were sprayed with 0.1 mg/ml fluorescamine in acetone to 
visualize the arginine and citrulline bands. These bands were scraped 
and the amount of [3H]arginine and [3H]citrulline was determined 
by scintillation counting. 
3. Results 
We first characterized NOS activity in the soluble 
fraction of the auditory nerve. [3H]citrulline was pro- 
duced by the auditory nerve in a linear t ime-dependent  
fashion in the presence but not in the absence of the 
NOS cosubstrate N A D P H  (Fig. 1). The production of 
citrulline could be abolished by first heating the en- 
zyme fractions at 100°C for 15 min (Fig. 1 inset). 
Enzyme-specific inhibitors confirmed that the ob- 
served conversion of arginine to citrulline was cat- 
alyzed by NOS. NG-methyl-L-arginine (NMMA) and 
the calmodulin antagonist trifluoperazine (TFP) are 
effective inhibitors of the neuronal type-I isoform [6]. 
Both of these compounds significantly reduced argi- 
nine to citrulline conversion catalyzed by cochlear tis- 
sues. In lateral wall, the soluble NOS activity of 2610 
dpm min-~ mg protein-~ was reduced by 73% or 96% 
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Fig. 1. NOS activity in auditory nerve. [3H]citruUine was separated 
from [3H]arginine by TLC as described in Methods. Arginine to 
citrulline conversion was observed in the presence of 10 mM NADPH 
(triangles) but not in its absence (squares). [3H]citrulline produced is 
expressed as the percentage of total radioactivity recovered from 
each time point. Inset: NADPH-dependent  citrulline production is 
abolished by prior incubation of the tissue at 100°C for 15 min. 
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Fig. 2. NOS inhibitors block cochlear NOS activity. NOS activity was 
assayed as described in Methods. Cytosolic NOS activity (black bars) 
was inhibited by either 50/.~M TFP (stippled bars) or 50/~M NMMA 
(unfilled bars) in auditory nerve and lateral wall. When TFP was 
tested, calmodulin was not added to the assay. Each point is the 
mean + S.D. of either 17 experiments (controls) or 3-8 experiments 
(inhibitors). Data are expressed as dpm citrulline produced rain-1 
mg protein-t. Statistical significance of differences between experi- 
ments in the absence and presence of inhibitors was determined by 
Student's t-test (* * P < 0.001). 
In auditory nerve, soluble actvitiy of 4090 dpm min-1 
mg protein -1 was reduced by 88% or 84% in the 
presence of 50 izM TFP or N M M A  respectively (Fig. 
2). 
NOS was present  in roughly equal specific activities 
in the lateral wall, auditory nerve, cochlear neuroep-  
ithelium, and pooled utricule and crista ampullaris 
tissues (Fig. 3). These activities ranged from 1343 to 
3092 dpm min-~ mg protein-~.  Also, the majority of 
the NOS activity was cytosolic indicating that the solu- 
ble NOS isoforms (type-I and type-II)  predominate  in 
the inner ear. Consistent with the finding in cochlear 
tissues, NOS activity in the vestibular tissues also could 
be completely inhibited by N M M A  in 2 independent  
experiments (data not shown). 
NADPH-diaphorase  histochemistry was performed 
to identify the cell types containing NOS in the cochlea. 
In brain, cells stained by this technique colocalize with 
cells recognized by NOS immunohistochemistry [10]. 
NADPH-diaphorase  histochemical staining in the coc- 
hear  neuroepithel ium labeled the nerve endings at the 
base of inner and outer hair cells, tunnel crossing 
fibers, tunnel and inner spiral bundles, and nerve fibers 
entering through the habenula perforata  (Fig. 4a,b). 
The finding that NADPH-diaphorase  activity was lo- 
cated at the base of outer hair cells was confirmed by 
experiments on isolated cells (Fig. 4c). In control ex- 
periments conducted in the absence of NADP,  no 
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Fig. 3. NOS activity in cochlear tissues. Cytosolic (solid) and particu- 
late (clear) NOS activity is found in auditory nerve (AN), lateral wall 
(LW), cochlear neuroepithelium (NE), and pooled utricle and cristae 
ampullaris (VS). No particulate NOS activity could be measured in 
the cochlear neuroepithelium. Assays were conducted in the pres- 
ence of 400,000 dpm of [3H]arginine for 60 min. Each point is the 
mean + S.D. of 6 independent experiments except for the vestibular 
tissues which were assayed 3 times. Statistical significance of differ- 
ences between particulate and cytosolic activities were assessed using 
Student's t-test (* 0.02 < P < 0.01, * * P < 0.001). 
staining was observed in the neuroepithelium (Fig. 4d) 
or the lateral wall (Fig. 4f). In the lateral wall tissues, 
the NADPH-diaphorase reaction stained the stria vas- 
cularis and the region of the spiral prominence (Fig. 
4e). No labeling of the spiral ligament was observed in 
cross-sections of stained lateral wall tissue (data not 
shown). 
4. Discussion 
NOS is present in the peripheral auditory system. 
NOS activity can be quantitated enzymatically in the 
auditory nerve, cochlear neuroepithelium, lateral wall, 
and vestibule. NADPH-diaphorase activity, which has 
been used to localize NOS in neural tissues [10] shows 
a distinct staining pattern in both the lateral wall and 
neuroepithelium. 
In the auditory nerve, NOS activity is predominantly 
cytosolic and can be inhibited by both NMMA and 
TFP, unique characteristics of the neuronal type-I iso- 
form [27]. This finding is in agreement with the neu- 
ronal nature of this tissue. In neurons, NO produced 
from type-I NOS can act as a neuromodulator or even 
as a neurotransmitter [5]. It is possible that NO pro- 
duced from type-I NOS may be playing a similar role 
in the auditory nerve. 
Similar to auditory nerve, NOS activity in the lateral 
wall is predominantly cytosolic and Ca2+/calmodulin - 
dependent thus indicating typed NOS activity. NOS 
can also be localized histochemically by NADPH-di- 
aphorase labeling. Type-III NOS could not be detected 
in our experiments as indicated by the lack of particu- 
late activity. The absence of type-III NOS activity is 
unexpected since this isozyme is generally associated 
with blood vessels and thus may be expected in the 
highly vascularized lateral wall tissue. Type-III NOS 
activity in the lateral wall may have been below the 
detection threshold of our assay, a distinct possibility 
since type-III NOS has the lowest catalytic rate of the 
three NOS isoforms [31]. Although NO can affect 
cochlear blood flow [4], the lack of type-III NOS as 
well as smooth muscle lining strial vessels indicates 
that NO blood flow regulation may occur at some 
other location or through some novel mechanism in the 
lateral wall. 
In the cochlear neuroepithelium, the NADPH-di- 
aphorase reaction labels the neural elements innervat- 
ing both inner and outer hair ceils. However, in some 
experiments, additional cell types such as interdental 
ceils of the spiral limbus, pillar, and Deiters' cells were 
stained. It should be noted that the correlation be- 
tween cells recognized by the NADPH-diaphorase 
technique and immunocytochemistry using anti-NOS-I 
antibodies is the strongest in neurons [10]. In non-neu- 
ronal cells in the peripheral olfactory tissues, 
NADPH-diaphorase staining results in labeling of non- 
NOS-I immunoreactive cells [17]. Thus, NADPH-di- 
aphorase labeling of cochlear supporting cells may not 
indicate the presence of NOS. In contrast, the combi- 
nation of NADPH diaphorase staining in the neuronal 
elements of the cochlear neuroepithelium and enzy- 
matic detection of NOS activity in this tissue strongly 
suggests that NOS is located in the neurons. 
In cochlear surface preparations, dense punctate 
staining is observed at the base of both inner and outer 
hair ceils. Studies on isolated outer hair cells confirm 
the presence of labeling at the base of the cell and also 
demonstrate the lack of stain in the cytoplasm. The 
labeling at the base of the outer hair cells is connected 
to the tunnel crossing fibers which also are identified 
by NADPH°diaphorase histochemistry. The staining 
pattern of the tunnel crossing fibers is very similar to 
Fig. 4. Localization of NOS in cochlear tissues using NADPH-diaphorase histochemistry. Cochlear neuroepithelium and lateral wall tissues were 
stained as described in Methods. A: in the cochlear neuroepithelium, nerve endings at the base of outer (arrow) and inner hair cells (arrowhead) 
are stained. B: the same area as in A at a different focal plane shows labeling in tunnel crossing fibers (CF), the inner spiral bundle (ISB), the 
tunnel spiral bundle (TSB) and fibers entering through the habenula perforata (arrow). C: nerve endings of isolated outer hair cells are stained 
(arrow). D: control. No staining is observed in the neuroepithelium in the absence of NADP. E: in the lateral wall, the region of  the stria 
vascularis (SV) and the spiral prominence (SP) is labeled. F: control labeling experiments as in D do not label the lateral wall. Scale bar = 10 p,m. 
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the pattern observed using anti-choline:acetyl- 
transferase immunocytochemistry which selectively 
stains efferent neurons in the organ of Corti [1]. Thus 
it is likely that NOS is located in efferent neurons 
innervating the outer hair ceils. Punctate NADPH-di- 
aphorase staining near inner hair cells is also observed 
and spiral ganglion cells can be labeled (data not 
shown) in agreement with a previous report [35]. Thus, 
NOS may also be located in type-I afferent neurons. In 
contrast, no NADPH-diaphorase labeling occurs in the 
cytoplasm of inner or outer hair cells. 
Most documented NO-mediated processes involve 
paracrine signalling whereby NO produced from one 
cell type diffuses to a neighboring cell type and affects 
its physiology. In the cochlea, a similar situation may 
exist whereby NO produced from nerve endings could 
diffuse to the hair cells and affect their physiology 
directly. 
In this fashion, NO could conceivably affect many 
hair cell processes. NO can lower the cytosolic free 
[Ca 2÷] in smooth muscle which leads to a change in 
cell shape [3]. By analogy, NO produced from efferent 
nerve endings could lower the cytosolic [Ca 2÷ ] in outer 
hair cells and affect their length which is Ca2+-depend - 
ent [13]. Thus, outer hair cell length and the microme- 
chanics of the basilar membrane could be modulated 
by NO-mediated efferent stimulation. Regulation of 
the cytosolic [Ca 2÷] could also affect other inner and 
outer hair cell processes such as neurotransmitter re- 
lease. Release of neurotransmitters is dependent on an 
increase in intracellular [Ca2+]. By lowering calcium 
levels in hair cells, NO could downregulate the release 
of neurotransmitter and affect cochlear sound trans- 
duction. 
NO is also a cytotoxin. Overstimulation of NOS-con- 
taining neurons by glutamate agonists leads to overpro- 
duction of NO and the death of surrounding neurons 
[11]. In the cochlea, excessive acoustic stimulation 
damages the afferent neurons innervating the inner 
hair cell. Perfusion of the glutamate receptor agonist 
AMPA into the cochlea mimics the excitotoxic damage 
[26] suggesting that overstimulaton of glutamate recep- 
tors is associated with this damage. Overstimulation of 
NOS located in the afferent nerve endings either 
through acoustic or glutamate stimulation could pro- 
duce excessive amounts of NO which could in turn 
damage the surrounding tissue. The presence of NOS 
in this region supports this hypothesis. Pharmacological 
intervention with NOS inhibitors should reduce this 
damage and thus may have some clinical benefits in the 
prevention of noise-induced hearing loss. 
In summary, NOS activity is present in several tis- 
sues of the inner ear including the auditory nerve~ 
lateral wall, vestibule and cochlear neuroepithelium. 
Based on subcellular fractionation and pharmacologi- 
cal characterization of this activity, the prominent iso- 
form in the cochlea is the neuronal type-I isozyme. 
NOS is localized to the stria vascularis as well as 
neurons synapsing on the inner and outer hair cells. 
Due to the wide range of effects attributed to NO in 
other systems, it is likely that NO is an important 
signalling molecule in the auditory system as well. 
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